Therefore, we performed immunohistochemical staining of pancreatic adenocarcinoma specimens from patients subjected to preoperative concurrent chemoradiotherapy (CCRT) to investigate the relationship between PLK1 protein expression level and prognosis. The gene discussed is PLK1; the disease is pancreatic adenocarcinoma.